Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

Circulating Cell-free DNA for Metastatic Cervical Cancer Detection, Genotyping, and Monitoring

Circulating cell-free DNA was used for detection, HPV genotyping, and monitoring in metastatic cervical cancer.

Clin Cancer ResPubMed 28899967DOI 10.1158/1078-0432.CCR-17-1553